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Summary
Aging constitutes the key risk factor for age-related diseases such
as cancer and cardiovascular and neurodegenerative disorders.
Human longevity and healthy aging are complex phenotypes
influenced by both environmental and genetic factors. The fact
that genetic contribution to lifespan strongly increases with
greater age provides basis for research on which “protective
genes” are carried by long-lived individuals. Studies have consis-
tently revealed FOXO (Forkhead box O) transcription factors as
important determinants in aging and longevity. FOXO proteins
represent a subfamily of transcription factors conserved from
Caenorhabditis elegans to mammals that act as key regulators of
longevity downstream of insulin and insulin-like growth factor
signaling. Invertebrate genomes have one FOXO gene, while
mammals have four FOXO genes: FOXO1, FOXO3, FOXO4, and
FOXO6. In mammals, this subfamily is involved in a wide range of
crucial cellular processes regulating stress resistance, metabolism,
cell cycle arrest, and apoptosis. Their role in longevity determi-
nation is complex and remains to be fully elucidated. Throughout
this review, the mechanisms by which FOXO factors contribute to
longevity will be discussed in diverse animal models, from Hydra
to mammals. Moreover, compelling evidence of FOXOs as
contributors for extreme longevity and health span in humans
will be addressed.
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Introduction
Aging can be generally defined has the functional deterioration of
physiological mechanisms which strictly depends on the passage of time.
This decline constitutes the key risk factor for age-related diseases such as
cancer and cardiovascular and neurodegenerative disorders. It is therefore
not surprising that humankind has put considerable efforts in understand-
ing the processes of aging (and how to delay them) since ancient times.
Human longevity and healthy aging are complex phenotypes influ-
enced by environmental (diet, physical activity, health habits, and
psychosocial factors) and genetic factors (Herskind et al., 1996;
Christensen et al., 2006; Bishop & Guarente, 2007). Heritability accounts
for 25% of lifespan in an average-lived population. The genetic
contribution of lifespan increases with greater age, particularly after the
age of 60, reaching estimates of 33% in women and 48% in men living
to at least 100 (Sebastiani & Perls, 2012; Brooks-Wilson, 2013).
Accordingly, longevity clusters within families as parents and siblings
of centenarians have an increased probability of reaching advanced age
(Perls et al., 2000, 2002; Atzmon et al., 2004; Willcox et al., 2006).
It has become increasingly evident that lifespan is closely related to
health span and that long-lived individuals develop chronic illnesses (both
physical and cognitive) later in life, thereby confirming the compression of
morbidity hypothesis proposed by Fries in 1980 (Fries, 1980; Hitt et al.,
1999; Andersen et al., 2012). A study performed in centenarians revealed
that there is a progressive compression of disability andmorbidity such that
at the remarkable survival age of 110, subjects presentedwith age-related
diseases in the last 5.2% of their lives (vs. 17.9% in controls, 9.4% in
individuals 100–104, and 8.9% in individuals 105–109) (Andersen et al.,
2012). As extreme longevity appears to be a result of genetic factors more
than environmental ones, when compared to an average lifespan,
significant effort has gone into determining which genetic variants can
slow aging and diminish the risk for age-related diseases. Interestingly, the
Leiden Longevity Study showed that, by GWAS, genomes of nonagenar-
ians carry the same number of disease risk alleles for coronary artery
disease, cancer and type 2 diabetes as young controls (Beekman et al.,
2010). These results hint toward the perception that these long-lived
individuals could carry “protective genes” that may work in general
cellular defensemechanisms, for example, against oxidative stress. In fact,
several studies have consistently revealed APOE and FOXOs (FOXO1 and
FOXO3) as “longevity genes” (Willcox et al., 2006; Anselmi et al., 2009;
Flachsbart et al., 2009; Soerensen et al., 2010, 2015; Brooks-Wilson,
2013; Bao et al., 2014; Broer et al., 2015). Aging has long been
considered a process of degradation occurring in a random fashion that
would lead to the accumulation of cellular damage in a stochastic fashion
and, consequently, tissue decline and death. However, it is now known
that aging can be modulated by genetic pathways and biochemical
processes which are evolutionarily conserved (Kenyon, 2010b; Lopez-Otin
et al., 2013). According to the quasi-programmed theory, aging is not
programmed, but rather a consequence of genetic programs that
determine developmental growth early in life (Blagosklonny, 2013a,b).
Lopez-Otin et al. (2013) in an attempt to define commondenominators of
aging in different organisms have defined nine cellular and molecular
hallmarks of aging: genomic instability, telomere attrition, epigenetic
alterations, loss of proteostasis, deregulated nutrient sensing, mitochon-
drial dysfunction, cellular senescence, stem cell exhaustion, and altered
intercellular communication.
Among these hallmarks, the “deregulated nutrient sensing” was the
first to be described to influence aging in animals, through the insulin
and IGF-1 signaling pathway (IIS) (Kenyon, 2005). IGF-1 is produced by
several cells types (mainly hepatocytes) in response to GH release from
the anterior pituitary. IGF-1 has been shown to trigger the same
intracellular signaling pathways stimulated by insulin. The IIS pathway is
the most evolutionarily conserved pathway of aging, shown to modulate
lifespan in model organisms across a great evolutionary distance from
Caenorhabditis elegans to mice (Kimura et al., 1997; Tatar et al., 2001;
Fontana et al., 2010; Kenyon, 2010b; Mercken et al., 2013). Accord-
ingly, genetic polymorphisms/mutations that cause loss of function of
GH, IGF-1 receptor, insulin receptor or its downstream factors, have
been implicated in human longevity as in model organisms (Fontana
et al., 2010; Kenyon, 2010b; Tazearslan et al., 2011; Barzilai et al.,
2012; Milman et al., 2014). Dietary restriction is a well-known environ-
mental signal shown to expand lifespan in eukaryote species, from yeast
to primates (Colman et al., 2009; Fontana et al., 2010; Mattison et al.,
2012). The “longevity response” to dietary restriction is regulated by
several nutrient-sensing pathways: the kinase TOR, AMP kinase, sirtuins,
and the IIS (Kenyon, 2005).
FOXO transcription factors
FOXO proteins are the most important transcriptional effectors of the IIS
(Kenyon et al., 1993; Gottlieb & Ruvkun, 1994; Brunet et al., 1999;
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Dong et al., 2008). FOXOs represent a subfamily of the Forkhead family
of transcription factors. This family is characterized by a conserved DNA-
binding domain (the Forkhead box or FOX) and comprises more than
100 members in humans, from FOXA to FOXS (Zanella et al., 2010;
Genin et al., 2014). The FOXO subfamily is conserved from C. elegans to
mammals but, while invertebrates have only one FOXO gene, mammals
have four FOXO genes: FOXO1 (FKHR), FOXO3 (FKHRL1), FOXO4 (AFX),
and FOXO6 (Kaestner et al., 2000; Hannenhalli & Kaestner, 2009). In
mammals, this subfamily is involved in a wide range of crucial cellular
processes regulating stress resistance, metabolism, cell cycle arrest, and
apoptosis, but their role in longevity still remains to be elucidated. FOXO
proteins function mainly as transcriptional activators by binding the
consensus core recognition motif TTGTTTAC, and their activity is
inhibited by the IIS pathway (Biggs et al., 1999; Brunet et al., 1999;
Henderson & Johnson, 2001; Lin et al., 2001; Calnan & Brunet, 2008;
Zanella et al., 2010; Webb & Brunet, 2014). Briefly, insulin or IGF-1
triggers an intracellular pathway mediated by PI3K-AKT, allowing
phosphorylation of FOXO factors by the serine/threonine kinase AKT at
three conserved residues within the FOXO proteins. AKT-mediated
phosphorylation of FOXO leads to its nuclear exclusion and, in turn, to
suppression of FOXO-dependent transcription of target genes (Guo
et al., 1999; Murphy et al., 2003). Conversely, in the absence of growth
factor signaling or upon cellular stress, FOXOs translocate into the
nucleus and activate FOXO-dependent gene expression. A diverse set of
posttranslational modifications in addition to phosphorylation, such as
acetylation/deacetylation, methylation, or ubiquitination has been
shown to promote changes of subcellular localization, protein levels,
DNA binding, and transcriptional activity of FOXO factors (Calnan &
Brunet, 2008; Webb & Brunet, 2014) The combinatorial result of FOXO
posttranslational modifications has been proposed to lead to the
recruitment of specific FOXO-binding partners regulating different
FOXO-dependent gene expression programs (Greer et al., 2007b;
Calnan & Brunet, 2008; Hill et al., 2014). Several mechanisms of how
FOXO proteins promote longevity have been suggested.
FOXO and autophagy
Webb & Brunet (2014) have recently unveiled the role of FOXOs as
prolongevity factors through the maintenance of protein homeostasis
(proteostasis) (Morley et al., 2002; Hsu et al., 2003). In fact, it has been
shown that FOXO factors participate in the regulation of genes
responsible for two main mechanisms of intracellular clearance:
autophagy and the ubiquitin-proteasome system (Webb & Brunet,
2014). Defects in autophagy, the process of degradation and recycling of
cytoplasmic proteins and organelles in response to starvation have been
associated with premature aging and age-related disorders (Hara et al.,
2006; Komatsu et al., 2006; Jung et al., 2008; Pickford et al., 2008;
Masiero et al., 2009; Lee et al., 2010). FOXOs affect the expression of
genes involved in autophagy and mitophagy (muscle-specific autophagy)
in muscle cells from flies (dFOXO) to mammals (FOXO3), allowing
adaptation of the tissues to starvation (Zhao et al., 2007; Sengupta
et al., 2009; Demontis & Perrimon, 2010). Additionally, FOXO1 and
FOXO3 activate autophagy mechanisms in diverse cell types: neurons,
cardiomyocytes, renal tubular cells, and HSCs (Webb & Brunet, 2014). As
mentioned, FOXOs are involved in the proteasome system degradation
of short-lived and regulatory cytosolic proteins. Aging is associated with
a decreased proteasomal activity, leading to excess of damaged proteins
in muscle, liver, and heart (Conconi et al., 1996; Petropoulos et al.,
2000; Bulteau et al., 2002; Husom et al., 2004). Moreover, pathogen-
esis of neurodegenerative disorders such as Parkinson’s, Alzheimer’s, or
Huntington’s disease is generally related to an abnormal ubiquitin-
proteasome mechanism as either a primary cause or secondary conse-
quence (Ciechanover & Brundin, 2003; Kikis et al., 2010; Webb &
Brunet, 2014). FOXOs act on both the upregulation of ubiquitin ligases
and by controlling the composition of the proteasome (Bodine et al.,
2001; Sandri et al., 2004, 2006; Stitt et al., 2004; Vilchez et al., 2012).
However, the direct effect of FOXO-mediated proteostasis in mammals
remains to be understood.
FOXO and resistance to oxidative stress
One of the most significant functions of FOXO proteins is their role in
cellular responses to oxidative stress. As accumulation of damage caused
by ROS (reactive oxygen species) was postulated to be causative for
aging, it has been hypothesized that FOXO factors influence aging and
age-related diseases by increasing the antioxidant capacity of cells (Kops
et al., 2002; Storz, 2011). ROS play an important role as second
messengers of cellular signaling and can lead to oxidative stress when
cellular detoxification activity is decreased. As high and very low levels of
ROS lead to impaired cellular functions, maintaining intracellular ROS
homeostasis is essential to prevent pathological processes including
cancer and other age-associated diseases. FOXOs are regulated by
oxidative stress via changes in upstream FOXO regulatory pathways or
directly sensing the cellular redox status through reversible oxidation and
reduction of cystein residues (Essers et al., 2004; Eijkelenboom &
Burgering, 2013; Putker et al., 2013). FOXO factors regulate the
expression of the key detoxification enzymes MnSOD (manganese
superoxide dismutase), catalase, and GADD45 (Kops et al., 2002;
Nemoto & Finkel, 2002). Accordingly, inactivation of Foxo factors has
been shown to lead to intracellular accumulation of ROS promoting
accelerated atherosclerosis, proliferation of transformed cells, and
compromising long-term proliferative potential of normal stem cells
(Tothova et al., 2007; Tsuchiya et al., 2013).
FOXO and stem cells
There is accumulating evidence that FOXO factors play an important role
in stem cell biology and tissue homeostasis. During aging, the balance of
removal and regeneration of cells in tissues becomes disturbed mainly
due to a decrease in the regenerative potential of adult stem cells.
Conditional deletion of Foxo1/3a/4 in the adult hematopoietic system of
mice leads to apoptosis of HSCs preventing the repopulation of these
stem cell populations. Similarly, aged mice in which Foxo3a was deleted
display reduced regenerative potential (Miyamoto et al., 2007). Foxo-
deficient HSCs in these animals are thought to be driven out of
quiescence into cell cycle, resulting in depletion of the stem cell pool
(Tothova & Gilliland, 2007). Interestingly, the treatment of Foxo-deficient
mice with the antioxidant N-acetylcysteine restores the HSC compart-
ment, suggesting that the accumulation of ROS disturbs stem cell
function. This observation is in line with the idea that decreased function
of adult stem cells involved in the onset of age-related diseases is
secondary to the accumulation of cellular stress (Boyette & Tuan, 2014).
The role of FOXO proteins in stem cell biology is not limited to adult stem
cells. FOXO1 has been shown to directly control the expression of OCT4
and SOX2 two transcription factors critically involved in stemness.
Accordingly, FOXO1 is necessary to maintain pluripotency of human ESC
and the ortholog FOXO1 exerts a similar function in mouse ESCs (Zhang
et al., 2011a).
In this review, we give an overview of the current evidence that
implicates FOXO transcription factors in human longevity. Although the
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precise mechanism by which FOXO factors influence human aging is not
understood, an overwhelming amount of data from several animal
models including Hydra vulgaris, C. elegans, Drosophila melanogaster,
and mice shed light on the critical functions of FOXO protein family
members in aging. We discuss the FOXO activities which might be
relevant for human longevity throughout this review organized by
species (Fig. 1).
Population studies
The understanding that the genetic contribution to lifespan strongly
increases with greater age provides basis for research on which genetic
differences distinguish centenarians from average-lived individuals (Her-
skind et al., 1996; Hjelmborg et al., 2006; Murabito et al., 2012;
Sebastiani & Perls, 2012; Brooks-Wilson, 2013). Accordingly, longevity
clusters within families as parents and siblings of centenarians present an
increased probability of reaching advanced age (Perls et al., 2000, 2002;
Atzmon et al., 2004; Willcox et al., 2006). Alleles which are enriched in
centenarians most likely represent genes that are significant for longevity
and therefore a significant number of studies have been done in the
quest for these alleles/genes.
Willcox et al. (2008) first reported that genetic variation in FOXO3A
was strongly associated with human longevity. In a long-lived population
of male Americans of Japanese ancestry (mean attained age = 97.9 vs.
control group = 78.5), a nested-case–control study of five candidate
genes (ADIPOQ, FOXO1A, FOXO3A, SIRT1, and COQ7) was performed.
Among these, only the rs2764264, rs13217795, and rs2802292
FOXO3A SNPs stood out as they were found to be associated with
longevity and healthy aging (Willcox et al., 2008). These long-lived men
had lower prevalence of cancer and cardiovascular disease better self-
reported health as well as high physical and cognitive function, even
though they were in average 11 years older than controls. Homozygosity
for the G allele of FOXO3A rs2802292 was shown to confer a significant
protection considering the prevalence of congestive heart disease. The
same allele was associated with markedly lower insulin, log insulin, and
HOMA (homeostasis model assessment) score in the control group
(Willcox et al., 2008).
Anselmi et al. (2009) validated the association of these FOXO3
polymorphisms with extreme longevity in males from the Southern
Italian Centenarian Study. In particular, rs2802288, a proxy of
rs2802292, showed the best allelic association-MAF (minor allele
frequency). These results were confirmed in the German population
(Flachsbart et al., 2009). An extensive collection of 1762 German
centenarians/nonagenarians and younger controls evidenced FOXO3A
polymorphisms with the ability to reach exceptional old age. This
association was substantially stronger in centenarians than in nonage-
narians, highlighting the importance of centenarians in genetic longevity
research (Flachsbart et al., 2009). Furthermore, the variation in FOXO3A
was replicated by both case–control and longitudinal data in Danish
population (the oldest-old vs. middle-aged individuals) (Soerensen et al.,
2010). Among the fifteen SNPs analyzed, they found association of eight
SNPs with longevity: four previously reported (rs13217795, rs2764264,
rs479744, and rs9400239) and four novel SNPs (rs12206094,
rs13220810, rs7762395, and rs9486902) (Soerensen et al., 2010).
Li et al. (2009) analyzed six SNPs from FOXO1A and FOXO3A genes
by comparing 761 centenarians and 1056 younger individuals (control
group) of the Han Chinese population. They found two SNPs of FOXO1A
to be negatively associated with longevity in women, rs2755209 and
rs2755213. On the other hand, all three SNPs studied for FOXO3A
(rs2253310, rs2802292, and rs4946936) were positively associated with
longevity in both genders (Li et al., 2009). They have concluded that as
FOXO1A is more strictly associated with human female longevity, the
genetic contribution to longevity trait may be affected by genders (Li
et al., 2009). Also in the Han Chinese population, Zeng et al. analyzed
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Fig. 1 The key components of the PI3K
signal transduction pathway are well
conserved throughout evolution. The
corresponding orthologues for these
components in Hydra, Caenorhabditis
elegans, Drosophila melanogaster and
mammals are illustrated. It is important to
note, that there is a single gene for many
components, in Hydra, C. elegans and D.
melanogaster whereas mammals have
several isoforms of these components with
the exception of PTEN. AGE-1, ageing
alteration 1; AKT, v-akt murine thymoma
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the independent and joint effects of the FOXO1A and FOXO3A SNPs on
long-term survival. These authors found substantial gender differences in
the independent effects and showed that the positive effects of FOXO3A
and negative effects of FOXO1A largely compensate each other,
although FOXO3A has a stronger impact (Zeng et al., 2010). Others
have also revealed the importance of genetic variations in the IIS
pathway in long-lived individuals from Italian, Japanese, Ashkenazi
Jewish, or Dutch ethnicity (Arai et al., 2001; Bonafe et al., 2003; Kojima
et al., 2004; Kuningas et al., 2007; Suh et al., 2008; Pawlikowska et al.,
2009). A meta-analysis comprising 11 independent case–control studies
and 5241 cases from different ethnic groups revealed five FOXO3A
polymorphisms as associated with longevity: rs2802292, rs2764264,
rs13217795, rs1935949, and rs2802288 (Bao et al., 2014). Moreover,
rs2802292 and rs2764264 polymorphism are male-specific longevity
polymorphisms that may potentially identify long-lived men. FOXO3A
along with APOE has consistently been associated with longevity in
multiple independent studies (Wheeler & Kim, 2011; Brooks-Wilson,
2013). Accordingly, Broer et al. (2015) conducted a meta-analysis of
GWAS with 6036 longevity cases (age ≥ 90 years) and 3757 controls
(CHARGE consortium). Among the ~2.5 million SNPs analyzed, only the
APOE and FOXO3 variants confirmed a significant association with
longevity (Broer et al., 2015). Recent work by Soerensen et al. (2015)
compared aging-related traits (cognitive function, hand grip strength,
activity of daily living, and self-rated health) with 15 FOXO3A SNPs in
Danish oldest-old individuals. Gene-based testing revealed a significant
increase in activity of daily living and reduced bone fracture risk for
carriers of the minor alleles of 8 and 10 FOXO3A SNPs, respectively
(Soerensen et al., 2015). In summary, gathered evidence from Japanese
Americans, Han Chinese, Californians, New Englanders, Ashkenazi Jews,
Danish, Germans, and Italians shows that FOXO3A SNPs are associated
with exceptional longevity. Although there is compelling evidence that
FOXO3 gene sequence variants influence longevity, it remains to be
determined how these variations translate into phenotypic characteristics
that enable a long lifespan. FOXO3A alleles associated with longevity are
intronic and not linked to known coding SNPs (Donlon et al., 2012;
Murabito et al., 2012; Brooks-Wilson, 2013), suggesting that these SNPs
will most likely affect FOXO3A expression rather than protein activity.
Animal models
Hydra vulgaris
Hydra vulgaris is a freshwater radial-symmetric polyp of the phylum
Cnidaria, placed at the basal root of the animal life. Bridge et al. (2010)
first described the presence of a single FoxO gene in Hydra. These
authors found significant parallels in the regulation of FoxO between
Hydra and bilaterian animals, showing that FoxO transcriptional activity
is negatively modulated by the PI3K/AKT/SGK pathway and, accordingly,
nuclear localization of a FoxO-GFP fusion protein is significantly
increased by a PI3K inhibitor (Bridge et al., 2010). Lasi et al. (2010)
showed that transient expression of FoxO-GFP protein induced an
apoptosis rate of 20–60% in Hydra epithelial cells. Conversely, co-
expression of one of the Hydra insulin-like genes with the FoxO-GFP
protein was shown to decrease the rate of apoptosis in these cells. As
the IIS acts through the PI3K/AKT/SGK pathway, one can hypothesize
that the IIS reduces Hydra0s FoxO activity (Lasi et al., 2010).
Hydra presents itself as unique model to study longevity due to its
extraordinary regenerative abilities through the self-renewal and differ-
entiating capacities of its epithelial and interstitial stem cells. These
properties are thought to be related to the fact that these animals
routinely reproduce asexually (Wittlieb et al., 2006; Khalturin et al.,
2007; Bosch, 2009; Bellantuono et al., 2015). Three stem cell lineages
allow this continuous self-renewal: ectodermal and endodermal epithe-
liomuscular stem cells and interstitial stem cells (Bosch, 2009; Bosch
et al., 2010). The search for transcriptome-specific signatures enabling
the regulation of self-renewal and differentiation showed that FoxO is
highly expressed in the three stem cell lineages of Hydra (Boehm et al.,
2012). The overexpression of FoxO in the multipotent interstitial stem
cell lineages increases stem cell and progenitor cell proliferation and
activates expression of stem cell genes in terminally differentiated
somatic cells (Boehm et al., 2012). Conversely, silencing FoxO in
epithelial cells increased the number of terminally differentiated cells
(Boehm et al., 2012) Altogether, these results suggest a key role for
FoxO in Hydra’s apparent biological immortality, specifically affecting its
continuous self-renewal capacity (Bellantuono et al., 2015). In a recent
essay, Schaible and Sussman hypothesized that whereas FoxO is
exclusively devoted to life-prolonging cell renewal in Hydra, the
evolutionary diversification of FoxO functions in multicellular eukaryotes
that manifest aging resulted in a dilution of FoxO’s rejuvenating capacity
(Schaible & Sussman, 2013).
Caenorhabditis elegans
Caenorhabditis elegans is a free-living unsegmented pseudocoelomate
member of the phylum Nematoda that has an average lifespan of about
2–3 weeks. It has two sexes: a self-fertilizing hermaphrodite and a male.
The life cycle of C. elegans is comprised of the embryonic stage, four
larval stages (L1–L4), and adulthood. If the environmental conditions are
not favorable (absence of food, high temperature, or presence of a
pheromone indicating high population density), L1 worms develop into
alternative larval form called the dauer larva (Fielenbach & Antebi, 2008).
The role of the IIS pathway in aging was first discovered in C. elegans
through mutations that extended lifespan. Mutations in DAF-2 (dauer
larvae formation-2), a hormone receptor similar to insulin and IGF-1
receptors, doubled the lifespan of the worm (Kenyon et al., 1993;
Kimura et al., 1997). This lifespan extension caused by DAF-2 mutations
required the activity of DAF-16, which encodes the single FoxO homolog
in C. elegans (Kenyon et al., 1993; Lin et al., 1997; Ogg et al., 1997).
DAF-16 is inactivated via its nuclear export by the evolutionary conserved
signaling pathway downstream of DAF-2 receptor (Henderson &
Johnson, 2001; Lee et al., 2001; Lin et al., 2001). HSF-1, the C. elegans
heat-shock transcription factor, is also required in DAF-2 mutants to
extend lifespan. HSF-1, along with DAF-16, promotes longevity by
activating specific longevity genes, including genes that encode small
heat-shock proteins (Garigan et al., 2002; Hsu et al., 2003; Walker &
Lithgow, 2003; Morley & Morimoto, 2004). The importance of DAF-18/
PTEN tumor suppressor in longevity and dauer larva formation, through
the regulation of the IIS pathway, has been established in the late 1990s
by several research groups (Ogg & Ruvkun, 1998; Gil et al., 1999;
Mihaylova et al., 1999; Rouault et al., 1999). DAF-18/PTEN has been
shown to regulate L1 arrest in the germ line, and insulin-like signaling
appears to be transduced by AGE-1/PI3K during L1 arrest (Weinkove
et al., 2006; Zhang et al., 2011b).
DAF-16 functions as the major target of the IIS pathway (Kenyon
et al., 1993; Gottlieb & Ruvkun, 1994). DAF-16/FoxO has been shown to
regulate hundreds of genes in C. elegans including those related to
stress response, antimicrobial activity, and metabolism, unveiling DAF-
16/FoxO as a central player of a complex network involving multiple
upstream pathways and downstream target genes (Lee et al., 2003;
McElwee et al., 2003; Murphy et al., 2003). The lifespan expansion
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effect accomplished by DAF-16/FOXO is most likely due to two isoform
variants DAF-16a and DAF-16d/f (Kwon et al., 2010; Chen et al., 2015).
Diverse approaches including different dietary regimens or using
compounds that mimic dietary restriction have been employed to
investigate the effect of dietary restriction on lifespan extension in
C. elegans (Kenyon, 2010b). Chronic food limitation increases lifespan
by downregulating TOR activity, which increases autophagy and
diminishes translation, probably through PHA-4/FOXA transcription
factor and S6 kinase, respectively, in a DAF-16/FoxO-independent
manner (Kaeberlein et al., 2005; Hansen et al., 2007; Pan et al., 2007;
Sheaffer et al., 2008). AMPK (AMP kinase), an energy sensor for cellular
AMP/ATP ratio that enables catabolic reactions for energy gain, has been
shown to respond to dietary restriction by increasing stress resistance
and extending longevity in C. elegans in a DAF-16/FOXO-dependent
manner (Apfeld et al., 2004; Greer et al., 2007a). AMPK directly
phosphorylates and activates DAF-16/FoxO (Greer et al., 2007a). Dietary
restriction with every-other-day feeding is likely to promote C. elegans
longevity via downregulation of the IIS pathway (Honjoh et al., 2009). In
C. elegans, overexpression of sirtuin gene sir-2.1 activates DAF-16/FoxO
by interacting with 14-3-3 proteins (Berdichevsky et al., 2006). The
ability of sirtuins to directly deacetylate DAF-16/FoxO together with the
fact that IIS pathway mutants do not need sir-2.1 to promote longevity,
suggests that sirtuins act on DAF-16/FoxO independently of the IIS
pathway (Kenyon, 2010b). Interestingly, whereas high levels of ROS led
to premature death, low concentrations caused a prolongation of
lifespan and this extension is dependent on both daf-16 and sir-2.1
genes (Heidler et al., 2010). Kim et al. (2014) have recently shown that
antioxidant treatment can extend the lifespan of C. elegans through the
phosphorylation and cytoplasmic retention of DAF-16/FoxO, involving
3-phosphoinositide-dependent kinase-1 (PDK-1).
Lee et al. showed that adding 2% glucose to bacterial diet of
C. elegans shortened the lifespan by inhibiting the activity of DAF-16/
FoxO and heat-shock factor HSF-1. This effect involves the downregu-
lation of an aquaporin glycerol channel, aqp-1, which is also inhibited by
glucose in mammals. Moreover, when 2% glucose was provided to
C. elegans insulin/IGF-1 receptor mutants, their lifespan extension was
nearly completed repressed (Lee et al., 2009). The expression of
components of the insulin/IGF-1 longevity pathway in subsets of cells
can affect the rate of aging of the entire organism, implying an active
coordination of the aging rates between the different tissues to establish
homeostasis. Murphy et al. (2007) reveal that in C. elegans, this
communication between the tissues is mediated by INS-7 (an insulin-
like peptide), which is regulated by DAF-16/FoxO activity in the intestine,
and that this regulation allows DAF-16 activity in the intestine to
influence DAF-16 activity in other tissues. But insulin-like peptides may
not be the only signals that act downstream of DAF-16/FoxO to influence
lifespan. In daf-16; daf-2 double mutants, the expression of DAF-16
specifically in one tissue (intestine/adipose tissue) can increase the worm
lifespan by 60% (Libina et al., 2003). As nonintestinal tissues do not
contain DAF-16/FOXO in these double mutant animals, it must influence
other downstream longevity signaling pathways in those tissues. The
secreted peptide SCL-1 is a candidate for such a downstream signal
(Ookuma et al., 2003).
Several reports indicate that FoxO induces autophagy acting in a non-
cell-autonomous manner, evidencing that proteostasis is beneficial for
longevity. Melendez et al. (2003) showed that autophagy is a cellular
pathway essential for dauer development and lifespan extension in
C. elegans (Melendez et al., 2003). Using daf-2 mutants, the authors
demonstrate that bec-1, the C. elegans ortholog of mammalian autop-
hagy gene APG6/VPS30/beclin1, is essential for normal dauer
morphogenesis and lifespan extension. Dauer formation is associated
with increased autophagy and requires autophagy genes APG1, APG7,
APG8, and AUT10 (Melendez et al., 2003). Accordingly, increased
autophagy is essential for lifespan extension in dietary restriction condi-
tions or TOR inhibition in C. elegans (Hansen et al., 2008). But, whereas
DAF-2 mutants require both autophagy and the transcription factor DAF-
16/FoxO to promote longevity, autophagy takes place in the absence of
DAF-16/FoxO. This may suggest that autophagy provides rawmaterial for
new macromolecular synthesis that requires the action of DAF-16/FoxO,
recycling thismaterial into cell-protective longevity proteins (Hansenet al.,
2008). In Salmonella-infected worms, inactivation of the autophagy
pathwaywas shown to increasebacterial intracellular replication, reducing
animal lifespan, culminating in an apoptotic-independent death (Jia et al.,
2009). Mutation of DAF-2 or overexpression of the DAF-16/FoxO
conferred pathogen resistance, which is precluded with the genetic
knockdown of autophagy genes (Jia et al., 2009).
Lifespan in C. elegans can also be modulated by its reproductive
system. The removal of the worm0s germ cells extends its life by 60%
(Hsin & Kenyon, 1999; Kenyon, 2010b). Germ line loss stimulates
nuclear accumulation of DAF-16/FoxO and the expression of the
transcription elongation/splicing factor homolog TCER-1 in intestinal
cells. Although the precise mechanism of how the information about the
reproductive status is transferred to the intestine is unclear, it has been
shown that the intestinal adaptor protein KRI-1 is required to induce
DAF-16/FoxO target gene expression and extend lifespan (Berman &
Kenyon, 2006; Ganapathy et al., 2010). This pathway is apparently
independent of the IIS and, accordingly, in daf-2 mutants, the loss of
germ line acts additively with the IIS to expand the long lifespan of these
mutants. Wang et al. (2008) proposed that this lifespan expansion may
be related to lipid metabolism, by showing that C. elegans germ line
stem cells actively promote systemic lipolysis via induction of a specific
triglyceride lipase, identified as lipl-4. As DAF-16/FoxO upregulates this
triglyceride lipase in response to germ line removal, it has been
suggested it may be involved in the pathway that allows DAF-16/FoxO
activity in the worm’s intestine/adipose tissue to influence C. elegans
lifespan (Wang et al., 2008; Kenyon, 2010a).
Drosophila melanogaster
Drosophila melanogaster, or fruit fly, is an invertebrate of the taxonomic
order Diptera. It has a lifespan of about 30 days and a four-stage life
cycle: egg, larva, pupa, and adult. Since 2001, it is known that the
downregulation of IIS could extend lifespan in the fruit fly D.
melanogaster, establishing the evolutionary conserved role of this
pathway in aging (Clancy et al., 2001; Tatar et al., 2001). Mutation of
Drosophila InR (insulin-like receptor) homologous to mammalian insulin
receptors yields dwarf females with up to an 85% extension of adult
longevity and dwarf males with reduced late age-specific mortality
(Clancy et al., 2001; Tatar et al., 2001). Conversely, treating these long-
lived InR-mutated dwarfs with a juvenile hormone analog restores life
expectancy toward that of wild-type controls (Clancy et al., 2001; Tatar
et al., 2001). Drosophila gene chico (named after the small size of the
correspondent mutants) encodes an insulin receptor substrate that
functions in the IIS pathway. Mutation of this gene extends fruit fly
median lifespan by up to 48% in homozygotes and 36% in heterozy-
gotes (Clancy et al., 2001). Importantly, this lifespan extension was not a
result of impaired oogenesis in chico females nor was correlated with
increased stress resistance (Clancy et al., 2001).
dFoxO, the equivalent of nematode DAF-16/FoxO and mammalian
FOXO3A, has been shown to be a key transcriptional regulator of the
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insulin pathway that modulates growth and proliferation in D.
melanogaster (Puig & Mattila, 2011). Without ligand binding at the
insulin-like receptor, dFoxO remains unphosphorylated and translocated
to the nucleus, activating expression of factors that retard cell growth
and proliferation (Junger et al., 2003; Puig et al., 2003). On the other
hand, insulin treatment leads to dFoxO phosphorylation by dAKT,
leading to cytoplasmic retention and inhibition of its transcriptional
activity. Mutant dFoxO lacking dAKT phosphorylation sites does not
respond to insulin inhibition and is constitutively active in the nucleus
(Puig et al., 2003). dFoxO activation induces growth arrest and increases
the expression of two key players of the dInR/dPI3K/dAKT pathway: the
translational regulator d4E-BP and the dInR itself. Interestingly, targeted
expression of dFoxO in fly tissues regulates organ size by specifying cell
number with no effect on cell size (Puig et al., 2003).
As in the worm, the nervous system has been shown to be implicated
in the IIS-mediated extension of lifespan in Drosophila (Fontana et al.,
2010). Drosophila has seven genes encoding insulin-like peptides (dilps),
and ablation of the cells expressing only three of the seven dilps in
neuroendocrine cells of the brain is sufficient to increase longevity
(Broughton et al., 2008). dFoxO has also been shown to regulate
D. melanogaster aging when activated specifically in the adult pericere-
bral fat body. This limited activation of dFoxO reduces expression of the
peptide dilp-2 synthesized in neurons and represses the IIS pathway in
peripheral fat body. These findings suggest that autonomous and
nonautonomous roles of insulin signaling concomitantly contribute to
control aging (Hwangbo et al., 2004).
Dietary restriction has been shown to affect the expansion of lifespan
in flies mediated by both TOR and IIS pathways (Kenyon, 2010b). The fall
in nutrients leads to a diminished TOR activity, increasing lifespan by two
possible mechanisms: by inhibiting general translation and increasing
respiration or by enhancing autophagy (Kenyon, 2010b).
Interestingly, life extension through dietary restriction does not
require dFoxO (Giannakou et al., 2008). Nevertheless, the overexpres-
sion of dFoxO in the adult fat body and gut of Drosophila showed an
altered response to dietary restriction, behaving as partially dietary
restricted. The authors suggest that, although dFoxO is unnecessary to
extend lifespan of flies in response to dietary restriction, the presence of
active dFoxO modulates the response to dietary restriction (Giannakou
et al., 2008). This likely occurs by changing the expression of dFoxO-
target genes, indicating that dFoxO may mediate the normal response to
dietary restriction (Giannakou et al., 2008). Min et al. (2008) showed
evidence that the diet-dependent effects of dFoxO overexpression on
fly’s lifespan are associated with reduction of dilp2.
The stress-responsive JNK pathway also requires dFoxO to extend
lifespan in Drosophila (Wang et al., 2005). JNK has been shown to
antagonize IIS, promoting dFoxO nuclear localization, therefore inducing
expression of growth control and stress defense genes. Moreover, the
repression of IIS ligands by JNK and dFoxO in neuroendocrine cells
systemically downregulates the IIS pathway (Wang et al., 2005).
As in C. elegans, dFoxO can regulate autophagy in Drosophila at an
organismal level. Overexpression of dFoxO or the dFoxO-target 4E-BP
in the muscle reduces protein aggregation in other tissues (brain,
adipose tissue, and retina), delaying muscle functional decay
and extending lifespan (Demontis & Perrimon, 2010). Moreover,
dFoxO/4E-BP overexpression in muscle decreases feeding behavior and
the release of insulin, therefore delaying the age-related accumulation
of protein aggregates in other tissues. These results reveal a non-cell-
autonomous mechanism mediated by dFoxO/4E-BP signaling in the
coordination of organismal and tissue aging (Demontis & Perrimon,
2010).
Mammals
The family of mammalian FOXO transcription factors comprises four
members. FOXO1, FOXO3, and FOXO4 are highly related, share the
same DNA-binding motifs, present similar patterns of expression, and
seem to have overlapping functions (Anderson et al., 1998; Biggs et al.,
2001; Jacobs et al., 2003; Obsil & Obsilova, 2011). FOXO6 is mainly
expressed in the brain and has been shown to be regulated by distinct
mechanisms. Interestingly, knockouts of single Foxo genes in mice
present with very distinct outcomes: Foxo1 knockout mice die in utero
due to defects in vasculature (Furuyama et al., 2004; Hosaka et al.,
2004). Female Foxo3 knockout mice were found to be sterile due to
global primordial follicle activation with subsequent oocyte exhaustion
(Castrillon et al., 2003; Hosaka et al., 2004). In addition, depletion of
Foxo3 resulted in deficient development of regulatory T cells with
consequent organ inflammation by a mechanism also involving Foxo1
(Harada et al., 2010; Kerdiles et al., 2010). Foxo4 and Foxo6 knockout
mice present with only mild phenotypes (Zhu et al., 2011; Salih et al.,
2012). Accordingly, conventional genetic analysis did not reveal an overt
tumor-prone or hematopoietic phenotype for the deficiency of any one
of the Foxo family members. As closely related members of gene families
may mask individual gene functions in single knockout experiments,
conditional alleles for Foxo1, Foxo3, and/or Foxo4 have been generated.
Paik et al. (2007) showed that triple knockout mice prompted a
progressive cancer-prone condition characterized by thymic lymphomas
and hemangiomas which lead to early death. This study established
mammalian Foxo proteins as bona fide tumor suppressors and confirm-
ing the functional redundancy of Foxo family members. However, it still
remains to be determined why these animals did not present neoplastic
phenotypes in epithelial tissues. Alternative downstream arms of the
PI3K/AKT pathway might play a more prominent trumorigenic role in
epithelial compartments. Conditional deletion of Foxo1, Foxo3, and
Foxo4 in the adult hematopoietic system resulted in a marked context-
dependent increase in ROS in Foxo-deficient HSC compared with wild-
type HSC that correlated with changes in expression of genes that
regulate ROS. The number and the long-term repopulating activity of
HSC were found to be significantly reduced in these animals (Tothova
et al., 2007). These results highlight the importance of mammalian Foxo
proteins for the long-term regenerative potential of HCS (Tothova &
Gilliland, 2007). Ablation of the three Foxo proteins resulted in an
increase in oxidative stress in bone and osteoblast apoptosis and a
decrease in the number of osteoblasts, the rate of bone formation and
bone mass (Ambrogini et al., 2010). Moreover, the overexpression of a
Foxo3 transgene in mature osteoblasts decreased oxidative stress and
osteoblast apoptosis and increased osteoblast number, bone formation
rate, and vertebral bone mass. These authors concluded that Foxos
provide an oxidative defense mechanism to deal with the aerobic
metabolism of osteoblasts, being indispensable for bone mass home-
ostasis (Ambrogini et al., 2010). Numerous research groups have used
the same approach to conditionally delete Foxo1, Foxo3, and Foxo4 in
different tissues, but the effect in aged knockout mice has not been
examined. There is no doubt that in the near future experiments will
shed light on this central aspect of FOXO biology. Intriguingly, recent
studies show that the life-extending effect of dietary restriction requires
Foxo3 but not Foxo1 in mice (Yamaza et al., 2010; Shimokawa et al.,
2015). The mechanism(s) by which Foxo factors contribute to lifespan
remain elusive. As previously mentioned, decreased autophagy has been
related to premature aging and age-related associated disorders (Hara
et al., 2006; Komatsu et al., 2006; Jung et al., 2008; Pickford et al.,
2008; Masiero et al., 2009; Lee et al., 2010). Foxo factors have been
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shown to regulate autophagy in mouse muscle, particularly Foxo3,
which induces the expression of several autophagy genes and increases
autophagosome formation (Mammucari et al., 2007; Zhao et al., 2007;
Webb & Brunet, 2014). Foxo1 and Foxo3 overexpression also promotes
mitophagy (degradation of mitochondria by the autophagy–lysosomal
pathway) by upregulating the expression of the mouse mitochondrial E3
ubiquitin protein ligase 1 (Lokireddy et al., 2012). Remarkably, Foxos
have also been implicated in the autophagy and mitophagy of neurons.
FOXO3 has been shown to control the accumulation of human
a-synuclein, a protein known to participate in the development of
Parkinson’s disease (Pino et al., 2014). Mild FOXO3 activity protects
nigral neurons against the accumulation of human a-synuclein by
promoting its degradation. These results suggest a determinant role for
FOXO3 in Parkinson’s disease, via neuronal survival in the substantia
nigra (Kume et al., 2010). Furthermore, FoxO1 and FoxO3 factors have
also shown to promote autophagy in rat neonatal cardiomyocytes and
primary renal proximal tubular cells (Sengupta et al., 2009; Kume et al.,
2010).
Warr et al. (2013) demonstrated that mouse HSCs robustly induce
autophagy and identified Foxo3A as critically important for rapid
induction of autophagy upon starvation. Interestingly, these authors also
showed that old HSCs retain an intact Foxo3A-driven pro-autophagy gene
program and that autophagy is required to maintain energy homeostasis
and promote survival of the HSCs (Warr et al., 2013).
Aging is associated with a decreased proteasomal activity, leading to
excess of damaged proteins in muscle, liver, and heart (Conconi et al.,
1996; Petropoulos et al., 2000; Bulteau et al., 2002; Husom et al.,
2004). Foxo3 has been shown to be a transcriptional regulator of
muscle-specific E3 ubiquitin ligases, which are major effectors of protein
degradation in muscle (Sandri et al., 2004, 2006; Stitt et al., 2004). But
FOXOs can also affect the composition of the proteasome. In particular,
FOXO4 has been shown to be required for the expression of the
proteasome component PSMD11 in human embryonic stem cells
(Vilchez et al., 2012).
Conclusions
An exciting research area on FOXO transcription factors’ impacting on
longevity has arisen in recent years. Studies have been conducted to
address their upstream regulation, their downstream effectors, and
respective signaling pathways in various animal models. Consequently,
how these FOXO-mediated programs affect cellular or tissue function
and whether there is an effect at an organismal level, has also been
scrutinized. Several lines of evidence suggest that FOXOs affect longevity
in a pleiotropic fashion, influencing several cell-regulated activities such
as stress resistance, metabolism, cell cycle arrest, and apoptosis.
A myriad of future work can be envisioned at this time. The induction
of FOXO-mediated programs in tissues with distinct metabolic potential
such as brain, muscle, or adipose tissue and with different stages of
differentiation or metabolic conditions (nutrition, oxidative stress) will
enlarge our knowledge of how FOXO factors affect cellular/organismal
lifespan. To further comprehend how FOXOs affect longevity, it is of
high importance to understand how human FOXO sequence variants
(namely FOXO3A) affect protein expression, its structure, or transcrip-
tional activity. In order to see how these variants translate into
physiological profiles, future investigations should address how these
variants affect the level of FOXO proteins and their downstream
effectors in serum. This approach has been used successfully in patients
with vitiligo, in which FOXO3A levels were shown to be decreased when
compared with the control group (Ozel Turkcu et al., 2014).
Compression of morbidity relates to both extended lifespan and
delayed onset of age-related diseases, such as cancer and cardiovascular
disorders. The development of molecules targeting aging mechanisms
that underlie a number of age-related diseases is an exciting field that is
nowadays in its first steps. It is noteworthy that clinical trials to test
lifespan extension in humans would be challenging and require markers
that can detect difference in aging rate across a short time frame. But
given the potential of FOXO proteins to impact on numerous disorders
such as cancer, diabetes, neurodegeneration, or immune system
dysfunction, novel therapeutic modalities based on FOXOs will most
likely take place in the near future.
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